Publications

Inflammatory Myopathies

• Inflammatory myopathies: evaluation and management. Greenberg SA. Semin Neurol. 2008;28:241-9.
• Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Walsh RJ, Kong SW, Yao Y, Jallal B, Kiener PA, Pinkus JL, Beggs AH, Amato AA, Greenberg SA. Arthritis Rheum. 2007;56:3784-92.
• Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Greenberg SA. Neurology. 2007;69:2008-19.
• A gene expression approach to study perturbed pathways in myositis. Greenberg SA. Curr Opin Rheumatol. 2007;19:536-41.
• Nuclear localization of valosin-containing protein in normal muscle and muscle affected by inclusion-body myositis. Greenberg SA, Watts GD, Kimonis VE, Amato AA, Pinkus JL. Muscle Nerve. 2007;36:447-54.
• A local antigen driven humoral response is present in the inflammatory myopathies. Bradshaw EM, Orihuela A, McArdel SL, Salajegheh M, Amato AA, Hafler DA, Greenberg SA, O’Connor KC. J Immunol 2007;178:547-556.
• Myeloid dendritic cells in inclusion-body myositis and polymyositis. Greenberg SA, Pinkus GS, Amato AA, Pinkus JL. Muscle Nerve 2007;35:17-23.
• Nuclear membrane proteins are present within rimmed vacuoles in inclusion body myositis. Greenberg SA, Pinkus JL, Amato AA. Muscle Nerve 2007;34:406-416.
• Plasma cells in muscle in inclusion body myositis and polymyositis. Greenberg SA, Bradshaw EM, Pinkus JL, Pinkus GS, Burleson T, Due B, Bregoli L, O’Connor KC, Amato AA. Neurology 2005;65:1782-1787.
• Interferon-alpha/beta mediated innate immune mechanisms in dermatomyositis. Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA. Ann Neurol 2005;57:664-678.I
• Uncertainties in the pathogenesis of adult dermatomyositis. Greenberg SA, Amato AA. Curr Opin Neurol 2004;17:359-364.
• Molecular profiles of inflammatory myopathies. Greenberg SA, Sanoudou D, Haslett J, Kohane I, Kunkel LM, Beggs AH, Amato AA. Neurology 2002;59:1170-1182.

Microarray Technology

• DNA microarray gene expression analysis technology and its application to neurological disorders. Greenberg SA. Neurology 2001;57:755-761.

Proteomics Applied to Muscle Disease (Abstracts Only)

• Parker K, Walsh R, Krastins B, Amato AA, Greenberg SA, Sarracino D. Proteomic Comparison of Muscle Biopsies from Inclusion Body Myositis, Non-specific Myositis, and Normal Muscle. Poster, American Society for Mass Spectrometry, Seattle, WA May 31, 2006.
• Walsh R, Sarracino D, Amato AA, Krastins B, Parker K, Greenberg SA. Sequential Solubilization of Proteins from Biopsies from Inclusion Body Myositis compared to Polymyositis or Normal Muscle: A Proteomic Analysis. Poster, American Society for Mass Spectrometry, Seattle, WA May 31, 2006.

Other

• Molecular Diagnosis of Inheritable Neuromuscular Disorders Part I. Genetic Determinants of Inherited Disease and Their Laboratory Detection. Greenberg SA, Walsh RJ. Muscle Nerve 2005;31:418-430.
• Molecular Diagnosis of Inheritable Neuromuscular Disorders Part II. The Application of Genetic Testing in Neuromuscular Disease. Greenberg SA, Walsh RJ. Muscle Nerve 2005;31:431-451.
• P-ANCA vasculitic neuropathy with 12-year latency between onset of neuropathy and systemic symptoms. Greenberg SA. BMC Neurology 2002;2:10-13.
• The history of dermatome mapping. Greenberg SA. Arch Neurol. 2003 Jan;60(1):126-31
• Acute demyelinating polyneuropathy with arsenic ingestion. Greenberg SA. Muscle Nerve 1996;19:1611-1613.
• Dejerine-Sottas Disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness: de novo dominant point mutation of the PMP22 gene. Ionasescu VV, Searby C, Greenberg SA. J Med Genet 1996;33:1048-1049.
• Neurologic thoracic outlet syndrome. Greenberg SA. Neurology 2002;59:E3 (Online NeuroImage).
• Acquired rippling muscle disease and myasthenia gravis. Greenberg SA. Muscle Nerve 2004;29:143-146.
• A neurological and hematological syndrome associated with zinc excess and copper deficiency. Greenberg SA, Briemberg HR. Journal of Neurology 2004;29:143-146
• Henry Head. Greenberg SA. J Neurol. 2004;251(9):1158-9.
• Factors prediciting extubation success in patients with Guillain-Barre syndrome. Nguyen TN, Badjatia N, Malhotra A, Gibbons FK, Qureshi MM, Greenberg SA. Neurocritical Care 2006 (In Press).

In Collaboration with Dr. Peter Park

• Discovering statistically significant pathways in expression profiling studies. Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS, Park PJ. Proc Natl Acad Sci USA 2005; 102(38):13544-9.
• Combining gene expression data from different generations of oligonucleotide arrays. Hwang KB, Kong SW, Greenberg SA, Park PJ. BMC Bioinformatics 2004;5:159.
• CrossChip: a system supporting comparative analysis of different generations of Affymetrix arrays. Kong SW, Hwang KB, Kim RD, Zhang BT, Greenberg SA, Kohane IS, Park PJ. Bioinformatics. 2005 May 1;21(9):2116-7.

In Collaboration with the Laboratories of Drs. Alan Beggs and Lou Kunkel

• Gene expression comparison of biopsies between Duchenne muscular dystrophy and normal skeletal muscle. Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH, Kunkel LM. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15000-5
• Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle. Sanoudou D, Haslett JN, Kho AT, Guo S, Gazda HT, Greenberg SA, Lidov HG, Kohane IS, Kunkel LM, Beggs AH. Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4666-71.
• Molecular classification of nemaline myopathies: “non-typing” specimens exhibit unique patterns of gene expression. Sanoudou D, Frieden LA, Haslett JN, Kho AT, Greenberg SA, Kohane IS, Kunkel LM, Beggs AH. Neurobiol Dis 2004;15:590-600.